Trial Profile
A multi-centre, randomised, open-label parallel groups study comparing the effectiveness and safety of treatment with Vytorin (Ezetimibe and Simvastatin) versus Lipitor (Atorvastatin) in subjects with a history of coronary heart disease and/or diabetes mellitus with uncontrolled lipids on statin therapy
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Atorvastatin
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms VyTUL
- Sponsors Organon
- 09 Jul 2011 New trial record